Please use this identifier to cite or link to this item: http://hdl.handle.net/2067/1577
Title: The use of filamentous bacteriophage fd to deliver MAGE-A10 or MAGE-A3 HLA-A2-restricted peptides and to induce strong antitumor CTL responses
Authors: Sartorius, Rossella
Pisu, Paola
D'Apice, Luciana
Pizzella, Luciano
Romano, Chiara
Cortese, Giancarlo
Giorgini, Angela
Santoni, Angela
De Berardinis, Piergiuseppe
Velotti, Francesca Romana
Keywords: Vaccine;Cytotoxic T lymphocytes;Tumor immunology;Bladder cancer
Issue Date: 2008
Publisher: American Association of Immunologists
Source: Sartorius, R. et al. 2008. The use of filamentous bacteriophage fd to deliver MAGE-A10 or MAGE-A3 HLA-A2-restricted peptides and to induce strong antitumor CTL responses. "Journal of Immunology" 180 (6): 3719-3728
Abstract: 
Delivery of tumor-associated antigen (TAA)-derived peptides in a high immunogenic form represents one of the key issues for effective peptide-based cancer vaccine development. Here, we report the ability of non-pathogenic filamentous bacteriophage fd virions to deliver HLA-A2-restricted MAGE-A10254-262- or MAGE-A3271-279-derived peptides and elicit potent specific CTL responses in vitro and in vivo. Interestingly, human anti-MAGE-A3271-279-specific CTLs were able to kill human MAGE-A3+ tumor cells, even if these cells naturally express a low amount of MAGE-A3271-279 peptide-HLA epitope surface complexes and are usually not recognized by CTLs generated by conventional stimulation procedures. MAGE-A3271-279-specific/CD8+ CTL clones were isolated from in vitro cultures and their high avidity for antigen recognition was assessed. Moreover, in vivo tumor protection assay showed that vaccination of humanized HHD (HLA-A2.1+/H2-Db+) transgenic mice with phage particles expressing MAGE-A3271-279-derived peptides hampered tumor growth. Overall, these data indicate that engineered filamentous bacteriophage virions increase substantially the immunogenicity of delivered TAA-derived peptides, thus representing a novel powerful system for the development of effective peptide-based cancer vaccines.
Description: 
L'articolo è disponibile sul sito dell'editore http://www.jimmunol.org
URI: http://hdl.handle.net/2067/1577
ISSN: 0022-1767
Appears in Collections:DECOS - Archivio della produzione scientifica

Files in This Item:
File Description SizeFormat
JImmunology1577.pdf111.56 kBAdobe PDFView/Open
Show full item record

Page view(s)

194
Last Week
0
Last month
4
checked on Mar 16, 2024

Download(s)

108
checked on Mar 16, 2024

Google ScholarTM

Check


All documents in the "Unitus Open Access" community are published as open access.
All documents in the community "Prodotti della Ricerca" are restricted access unless otherwise indicated for specific documents